University of Chile study: Our results indicate that mutations present in the spike protein of the Lambda variant of interest confer increased infectivity and immune escape from neutralizing antibodies elicited by CoronaVac.

WHO: Further studies are … required to validate the continued effectiveness of vaccines.

The old 'further studies' line. Still waiting to see proper studies on the Delta variant.

I guess I'll have another drink just for old times!

Confident we'll get that drink in one day - might be the 'cafe at the end of the universe' but we'll get there ...